COVID19 vaccine ICD10PCS codes for exposure identification

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 6
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2022-01-06T01:02:20-05:00",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "BEST System Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: COVID-19 vaccine ICD10PCS codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: COVID-19 vaccine ICD10PCS codes.),(Exclusion Criteria: None)",
  "name" : "COVID19VaccineICD10PCSCodesForExposureIdentification",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW013S6",
      "display" : "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    }, {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW013T6",
      "display" : "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    }, {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW013U6",
      "display" : "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    }, {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW023S6",
      "display" : "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    }, {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW023T6",
      "display" : "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    }, {
      "system" : "http://www.cms.gov/Medicare/Coding/ICD10",
      "code" : "XW023U6",
      "display" : "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6",
      "version" : "2025"
    } ],
    "total" : 6,
    "identifier" : "urn:uuid:fb288af4-a12a-423f-9939-9a578927b75c",
    "timestamp" : "2024-12-10T08:43:06-05:00"
  },
  "title" : "COVID19 vaccine ICD10PCS codes for exposure identification",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "BEST System Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-04-04",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2022-01-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "fc9e8540-23b3-413c-a740-71387f8e982c",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1234.75"
  } ],
  "version" : "20220106"
}